Cytek Biosciences Stock Forecast - Semi Variance
| CTKB Stock | USD 6.53 0.03 0.46% |
Cytek Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cytek Biosciences stock prices and determine the direction of Cytek Biosciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cytek Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
Cytek |
| Check Cytek Biosciences Volatility | Backtest Cytek Biosciences | Information Ratio |
Cytek Biosciences Trading Date Momentum
| On November 29 2024 Cytek Biosciences was traded for 6.53 at the closing time. The top price for the day was 6.61 and the lowest listed price was 6.46 . The trading volume for the day was 519.3 K. The trading history from November 29, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.15% . |
| Compare Cytek Biosciences to competition |
Other Forecasting Options for Cytek Biosciences
For every potential investor in Cytek, whether a beginner or expert, Cytek Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cytek Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cytek. Basic forecasting techniques help filter out the noise by identifying Cytek Biosciences' price trends.Cytek Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytek Biosciences stock to make a market-neutral strategy. Peer analysis of Cytek Biosciences could also be used in its relative valuation, which is a method of valuing Cytek Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cytek Biosciences Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cytek Biosciences' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cytek Biosciences' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cytek Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Cytek Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytek Biosciences shares will generate the highest return on investment. By undertsting and applying Cytek Biosciences stock market strength indicators, traders can identify Cytek Biosciences entry and exit signals to maximize returns.
| Accumulation Distribution | 11785.01 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 6.54 | |||
| Day Typical Price | 6.53 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.03 |
Cytek Biosciences Risk Indicators
The analysis of Cytek Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cytek Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cytek stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.2 | |||
| Semi Deviation | 3.91 | |||
| Standard Deviation | 5.65 | |||
| Variance | 31.91 | |||
| Downside Variance | 17.85 | |||
| Semi Variance | 15.25 | |||
| Expected Short fall | (3.37) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cytek Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytek Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytek Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytek Biosciences Stock:Check out Historical Fundamental Analysis of Cytek Biosciences to cross-verify your projections. For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytek Biosciences. If investors know Cytek will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytek Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.658 | Earnings Share (0.08) | Revenue Per Share 1.527 | Quarterly Revenue Growth 0.073 | Return On Assets (0.03) |
The market value of Cytek Biosciences is measured differently than its book value, which is the value of Cytek that is recorded on the company's balance sheet. Investors also form their own opinion of Cytek Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cytek Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytek Biosciences' market value can be influenced by many factors that don't directly affect Cytek Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytek Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytek Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytek Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.